Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?

Benoit Souchet, Mickael Audrain, Baptiste Billoir, Laurent Lecanu, Satoru Tada, Jérôme Braudeau

Research output: Contribution to journal › Short survey › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	224-225
Number of pages	2
Journal	Neural Regeneration Research
Volume	13
Issue number	2
DOIs	https://doi.org/10.4103/1673-5374.226389
State	Published - Feb 2018
Externally published	Yes

Access to Document

@article{eb1f046cab5a4cf49ba9104cc7bf91b4,

title = "Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?",

author = "Benoit Souchet and Mickael Audrain and Baptiste Billoir and Laurent Lecanu and Satoru Tada and J{\'e}r{\^o}me Braudeau",

year = "2018",

month = feb,

doi = "10.4103/1673-5374.226389",

language = "English",

volume = "13",

pages = "224--225",

journal = "Neural Regeneration Research",

issn = "1673-5374",